Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: Comparison with dynamic CT

British Journal of Radiology

Volumn 84, Issue 1002, 2011, Pages 499-507

  Mandai, M ^a   Koda, Masahiko ^a   Matono, T ^a   Nagahara, T ^a   Sugihara, T ^a   Ueki, M ^a   Ohyama, K ^a   Murawaki, Y ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUBUTANE;

AGED; ALCOHOLISM; ARTICLE; CANCER RECURRENCE; CHRONIC HEPATITIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CRYPTOGENIC LIVER DISEASE; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KUPFFER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MICROBUBBLE; PERCUTANEOUS BIOPSY; TUMOR VOLUME; VASCULAR TUMOR;

AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; FLUOROCARBONS; HUMANS; IMAGE ENHANCEMENT; KUPFFER CELLS; LIVER NEOPLASMS; MALE; MICROBUBBLES; NEOPLASM RECURRENCE, LOCAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79956358980     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/38682601     Document Type: Article

References (33)

1. Tanaka S, Kitamura T, Fujita M, Nakanishi K, Okuda S. Color Doppler flow imaging of liver tumors. Am J Roentgenol 1990;154:509-14. (Pubitemid 20071599)
2. Lencioni R, Pinto F, Armillotta N, Bartolozzi C. Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US. Radiology 1996;201:353-8. (Pubitemid 26357625)
3. Winter TC, 3rd, Takayasu K, Muramatsu Y, Furukawa H, Wakao F, Koga H, et al. Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation. Radiology 1994;192:379-87. (Pubitemid 24233914)
4. Takayasu K, Muramatsu Y, Furukawa H, Wakao F, Moriyama N, Takayama T, et al. Early hepatocellular carcinoma: appearance at CT during arterial portography and CT arteriography with pathologic correlation. Radiology 1995;194:101-5. (Pubitemid 24380932)
5. Hayashi M, Matsui O, Ueda K, Kawamori Y, Kadoya M, Yoshikawa J, et al. Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. Am J Roentgenol 1999;172:969-76. (Pubitemid 29505622)
6. Stark DD, Weissleder R, Elizondo G, Hahn PF, Saini S, Todd LE, et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1998;168:297-301.
7. Imai Y, Murakami T, Yoshida S, Nishikawa M, Ohsawa M, Tokunaga K, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 2000;32:205-12. (Pubitemid 30614651)
8. Fujimoto M, Moriyasu F, Nishikawa K, Nada T, Okuma M. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings. Am J Roentgenol 1994;163:1099-104. (Pubitemid 24355699)
9. Choi BI, Kim TK, Han JK, Kim AY, Seong CK, Park SJ. Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US. Radiology 2000;214:381-6. (Pubitemid 30077692)
10. Lencioni R, Cioni D, Bartolozzi C. Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound. Eur Radiol 2002;12:151-65. (Pubitemid 36940043)
11. Hirai T, Ohishi H, Tokuno E, Takahashi M, Sakaguchi H, Anai H, et al. Qualitative diagnosis of hepatocellular carcinoma by contrast enhanced ultrasonography using coded harmonic angio with Levovist. J Med Ultrasonics 2002;29:3-9. (Pubitemid 34456705)
12. Koda M, Matsunaga Y, Ueki M, Maeda Y, Mimura K, Okamoto K, et al. Qualitative assessment of tumor vascularity in hepatocellular carcinoma by contrast-enhanced coded ultrasound: comparison with arterial phase of dynamic CT and conventional color/power Doppler ultrasound. Eur Radiol 2004;14:1100-8. (Pubitemid 38787255)
13. Sontum PC. Physicochemical characteristics of sonazoid™, a new contrast agent for ultrasound imaging. Ultrasound Med Biol 2008;34:824-33. (Pubitemid 351608046)
14. Waranabe R, Matsumura M, Chen C-J, Kaneda Y, Fujimaki M. Characterization of tumor imaging with microbubble-based ultrasound contrast agent, sonazoid, in rabbit liver. Biol Pharm Bull 2005;28:972-7. (Pubitemid 40880299)
15. Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H. Phagocytosis of ultrasound contrast agent microbubbles by Kuppfer cells. Ultrasound Med Biol 2007;33:318-5.
16. Ding H, Kudo M, Maekawa K, Suetomi Y, Minami Y, Onda H. Detection of tumor parenchymal blood flow in hepatic tumors: value of second harmonic imaging with a galactose-based contrast agent. Hepatol Res 2001;21:242-51. (Pubitemid 33061721)
17. Leen E. The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Eur Radiol 2001;11:E27-34.
18. Dill-Macky MJ, Burns PN, Khalili K, Wilson SR. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology 2002;222:95-102. (Pubitemid 34031472)
19. Nicolau C, Brú C. Focal liver lesions: evaluation with contrast-enhanced ultrasonography. Abdom Imaging 2004;29:348-59. (Pubitemid 38590819)
20. Quaia E, Calliada F, Bertolotto M, Rossi S, Garioni L, Rosa L, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004;232:420-30. (Pubitemid 38971282)
21. Gaiani S, Celli N, Piscaglia F, Cecilioni L, Losinno F, Giangregorio F, et al. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 2004;41:421-6. (Pubitemid 39158751)
22. Xu H-X, Liu G-J, Lu M-D, Xie X-Y, Xu Z-F, Zheng Y-L, et al. Characterization of focal liver lesions using contrastenhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound 2006;34:261-72. (Pubitemid 44015493)
23. Liu G-J, Xu H-X, Lu M-D, Xie X-Y, Xu Z-F, Zheng Y-L, et al. Enhancement pattern of hepatocellular carcinoma: comparison of real-time contrast-enhanced ultrasound and contrast- enhanced computed tomography. Clin Imaging 2006;30:315-21. (Pubitemid 44216143)
24. Xu H-X, Xie X-Y, Lu M-D, Liu G-J, Xu Z-F, Zheng Y-L, et al. Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma ≤2 cm. J Clin Ultrasound 2006;36:257-66.
25. Giorgio A, Ferraioli G, Tarantino L, Stefano G, Scala V, Scarano F, et al. Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance. AJR 2004;183:1319-26. (Pubitemid 44210595)
26. Liu k, He X, Lei X-Z, Zhao L-S, Tang H, Liu L, et al. Pathomorphological study on location and distribution of Kupffer cells in hepatocellular carcinoma. World J Gastroenterol 2003;9:1946-9.
27. Inoue T, Kudo M, Hatanaka K, Takahashi S, Kitai S, Ueda T, et al. Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Oncology 2008;75:48-54.
28. Korenaga K, Korenaga M, Furukawa M, Yamazaki T, Sakaida I. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images. J Gasroenterol 2009;44:733-41.
29. Leen E. The role of contrast-enhanced ultrasound in the characterization of focal liver lesions. Eur Radiol 11:E27-E34.
30. Hatanaka K, Kudo M, Minami Y, Ueda T, Tatsumi C, Kitai S, et al. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008;51:S61-S69.
31. Quaia E, Bertolotto M, Dalla Palma L. Characterization of liver hemangiomas with pulse-inversion harmonic imaging. Eur Radiol 2002;12:537-44. (Pubitemid 36940097)
32. Nunata K, Morimoto M, Ogura T, Sugimoto K, Takebayashi S, Okada M, et al. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. J Ultrasound Med 2008;27:395-406. (Pubitemid 351428123)
33. Xia Y, Kudo M, Minami Y, Hatanaka K, Ueshima K, Chung H, et al. Responase evaluation of transcatheter arterial chemoembolisation in hepatocellular carcinoma: the usefulness of Sonazoid-enhanced harmonic sonography. Oncology 2008;75:S99-S105.